Literature DB >> 33557774

LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.

Wei Zhao1, Jing Zhao2, Xiao Guo3, Yujie Feng4, Bingyuan Zhang4, Lantian Tian4.   

Abstract

BACKGROUND: Cholangiocarcinoma is a common malignant tumor of digestive system. LncRNA metallothionein 1 J, pseudogene (MT1JP) has been reported to play tumor-suppressing roles in multiple cancers. However, its effect on cholangiocarcinoma has not been evaluated.
METHODS: The expression of MT1JP in intrahepatic cholangiocarcinoma specimens and paired para-carcinoma tissues were detected by real-time PCR. The overexpression plasmid and siRNA of MT1JP were transfected into intrahepatic cholangiocarcinoma cells to change the expression levels of MT1JP. CCK-8, flow cytometry and transwell assays were performed to measure proliferation, cell cycle transition, apoptosis, migration and invasion. Dual-luciferase reporter assay, real-time PCR and western blot were carried out to screen the miRNA bound by MT1JP. In addition, xenograft experiment was used to determine the tumorigenesis of cholangiocarcinoma cells in nude mice.
RESULTS: MT1JP was downregulated in intrahepatic cholangiocarcinoma specimens, and its expression was related with TNM stage and lymph node metastasis. Overexpression of MT1JP inhibited proliferation, cell cycle transition, migration and invasion, and induced apoptosis in intrahepatic cholangiocarcinoma cells. The knockdown of MT1JP led to opposite results. MT1JP bound to miR-18a-5p to facilitate the expression of fructose-1,6-bisphosphatase 1 (FBP1). MiR-18a-5p was increased in intrahepatic cholangiocarcinoma samples, and its expression was negatively correlated with that of MT1JP. In addition, MT1JP also suppressed tumorigenesis in nude mice.
CONCLUSIONS: MT1JP alleviated proliferation, migration and invasion, and induced apoptosis in cholangiocarcinoma cells by regulating miR-18a-5p/FBP1 axis. These findings may provide novel insights for clinical diagnosis and treatment of cholangiocarcinoma.

Entities:  

Keywords:  Cholangiocarcinoma; MT1JP; Tumor; lncRNA; miRNA

Mesh:

Substances:

Year:  2021        PMID: 33557774      PMCID: PMC7871555          DOI: 10.1186/s12885-021-07838-0

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  24 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Fast and effective prediction of microRNA/target duplexes.

Authors:  Marc Rehmsmeier; Peter Steffen; Matthias Hochsmann; Robert Giegerich
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

Review 3.  Risk factors for cholangiocarcinoma.

Authors:  Gia L Tyson; Hashem B El-Serag
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 4.  Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Authors:  Sumera Rizvi; Shahid A Khan; Christopher L Hallemeier; Robin K Kelley; Gregory J Gores
Journal:  Nat Rev Clin Oncol       Date:  2017-10-10       Impact factor: 66.675

Review 5.  Mechanism of action of fructose 1,6-bisphosphatase.

Authors:  S J Benkovic; M M deMaine
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1982

6.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

7.  Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.

Authors:  Xiao-Yong Huang; Ai-Wu Ke; Guo-Ming Shi; Zhen-Bin Ding; Ranjan Prasad Devbhandari; Fang-Ming Gu; Quan-Lin Li; Zhi Dai; Jian Zhou; Jia Fan
Journal:  Cancer       Date:  2010-08-16       Impact factor: 6.860

8.  Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.

Authors:  Liang Zhou; Zuwei Li; Xiang Pan; Yulin Lai; Jing Quan; Liwen Zhao; Jinling Xu; Weijie Xu; Xin Guan; Hang Li; Shangqi Yang; Yaoting Gui; Yongqing Lai
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 9.  Cholangiocarcinoma.

Authors:  Boris R A Blechacz; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2008-02       Impact factor: 6.126

10.  LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.

Authors:  Ying Xu; Guohua Zhang; Chen Zou; Heng Zhang; Zhigang Gong; Weixin Wang; Gui Ma; Pengcheng Jiang; Wenbo Zhang
Journal:  Cell Physiol Biochem       Date:  2018-05-05
View more
  6 in total

1.  Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway.

Authors:  Dekang Wang; Aili Hu; Hao Peng; Dongbo Li; Li Zhang
Journal:  3 Biotech       Date:  2021-07-23       Impact factor: 2.893

2.  NOV/CCN3 Promotes Cell Migration and Invasion in Intrahepatic Cholangiocarcinoma via miR-92a-3p.

Authors:  Tingming Liang; Lulu Shen; Yaya Ji; Lin Jia; Yuyang Dou; Li Guo
Journal:  Genes (Basel)       Date:  2021-10-21       Impact factor: 4.096

3.  LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9.

Authors:  Lei Xiao; Weijie Yuan; Changhao Huang; Qingqing Luo; Runsha Xiao; Zi-Hua Chen
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

4.  Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.

Authors:  Lang Jia; Yun Zhang; Feng Pu; Chong Yang; Shula Yang; Jinze Yu; Zihan Xu; Hongji Yang; Yu Zhou; Shikai Zhu
Journal:  Aging (Albany NY)       Date:  2022-02-27       Impact factor: 5.682

Review 5.  The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.

Authors:  Lu Xia; Jingyun Chen; Min Huang; Jie Mei; Min Lin
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

Review 6.  Current Advances in Basic and Translational Research of Cholangiocarcinoma.

Authors:  Keisaku Sato; Leonardo Baiocchi; Lindsey Kennedy; Wenjun Zhang; Burcin Ekser; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Cancers (Basel)       Date:  2021-07-01       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.